Girish Venkataraman to Prospective Studies
This is a "connection" page, showing publications Girish Venkataraman has written about Prospective Studies.
Connection Strength
0.055
-
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
Score: 0.031
-
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799.
Score: 0.024